FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GLOBALDATA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CRANEWARE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Press Release dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 2, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, today announces the successful completion of the sale of its stake in the Feed Enzymes Alliance to its partner Novonesis, a global leader in biosolutions, for €1.5 billion. The sale agreement was announced on February 11, 2025. dsm-firmenich received approximately €1.4 billion net in cash, after transaction costs. About dsm-firmenichAs innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned...

Novonesis has successfully completed the acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance following the satisfaction of all closing conditions. The acquisition was initially announced on February 11, 2025 (announcement No 2). Please read the full announcement in PDF.Attachment2025_Closing_of_the_Feed_Enzyme_Alliance

Press release Atos Group receives confirmatory offer from the French State to acquire part of its former Advanced Computing business Vision AI activities excluded from the transactionConfirmatory offer received from the French State to acquire Eviden’s Advanced Computing business excluding newly separated Vision AI activities Enterprise Value of €410 million including €110 million contingent earn outs, following the exclusion of Vision AI activities Vision AI activities, contributing to more than one third of the operating margin of the formerly considered perimeter, repositioned in Eviden to structure a new business unit The Parties aim to sign a binding agreement1 in the coming weeks, with a closing of the transaction expected in 2026Paris, France – June 2, 2025 – Following its press release dated November 25, 2024, Atos SE (“Atos”...

VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) — Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster”), is pleased to announce it has received approval from the Canadian Securities Exchange to complete the acquisition of the Lake Cargelligo Gold Project and has today completed the $400,000 non-brokered private placement financing as announced on April 23, 2025, which was fully subscribed. With all key conditions met, Lancaster expects the acquisition to close imminently. Lake Cargelligo Gold Project Highlights:District-scale opportunity: 28,768 hectares in a single, contiguous claim with over 25 km of prospective strike and three primary target zones.High-grade results: Historical sampling includes results up to 204 g/t Au and 273 g/t Ag from rock chips, and up to 16m @ 5.83 g/t Au and 7.20...

Acquisition will help more organizations transition to the IGEL OS Platform and the IGEL Adaptive Secure DesktopIGEL Acquires Stratodesk, Expanding its Customer Base and Strengthening its Team in Secure Endpoint ComputingIGEL Acquires Stratodesk, Expanding its Customer Base and Strengthening its Team in Secure Endpoint ComputingFORT LAUDERDALE, Fla., May 30, 2025 (GLOBE NEWSWIRE) — IGEL, the transformative secure endpoint OS Platform designed for Enterprise Browser, SaaS, DaaS and VDI environments, today announced that it has completed its acquisition of Stratodesk, a recognized provider of endpoint OS software and management solutions. The acquisition will expand IGEL’s customer base, accelerating its mission to help enterprises modernize their endpoint strategy with a more secure, cost-effective, and cloud-ready OS....

LOS ANGELES, May 30, 2025 (GLOBE NEWSWIRE) — Flexi-View Lending is proud to announce the successful closing of a $9.5 million commercial loan to support a strategic property acquisition in Dallas, Texas. The loan was secured on an expedited timeline, closing in just 30 days—demonstrating Flexi-View Lending’s commitment to efficient and responsive financing solutions. The 34-month term loan was originated by James McDonough, a seasoned commercial lending professional known for structuring competitive financial solutions tailored to complex real estate transactions. With an interest rate of 10.75%, the financing enables the borrower to act swiftly on a high-value investment opportunity in one of the nation’s most dynamic real estate markets. “This transaction reflects our ongoing mission to provide flexible, timely, and high-impact...

Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up to $4.8 million, plus a 2.5% royalty on future net sales of UNLOXCYT™ (cosibelimab-ipdl) MIAMI, May 30, 2025 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced that its subsidiary, Checkpoint Therapeutics, Inc. (“Checkpoint”), has been acquired by Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or associated companies, “Sun Pharma”). The transaction closed on May 30, 2025, following the approval by requisite majorities of holders of Checkpoint’s...

PRESS RELEASE Wolters Kluwer acquires online healthcare courseware provider IntelliLearn Waltham — May 30, 2025 — Wolters Kluwer Health today announced it has acquired IntelliLearn Pty Ltd., a provider of online courseware solutions for nursing schools in Australia and the U.S. IntelliLearn will become part of Wolters Kluwer’s Health, Learning, Research & Practice (HLRP) business, a leader in nursing education and practice solutions. “We’re pleased to be adding the IntelliLearn solutions to our Lippincott suite of nursing products,” said Julie Stegman, Vice President and General Manager, Wolters Kluwer Health, Learning & Practice. “The IntelliLearn solutions, including medication safety and other medical math content, allow us to offer an even broader range of training modules to prepare nursing students for practice.” Founded...